Dr. Durga Borkar, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Northwestern University Feinberg Medical School (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 331
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: Northwestern University Feinberg Medical School
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
PA license MD460186
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 331
- Services billed
- 9,566
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 2,472 | 13 |
| Imaging of retina | 740 | 318 |
| Injection, aflibercept, 1 mg | 326 | 39 |
| Established patient office or other outpatient visit, 30-39 minutes | 266 | 184 |
| Injection of drug into eye | 264 | 64 |
| Established patient office or other outpatient visit, 20-29 minutes | 198 | 155 |
| Injection, bevacizumab, 10 mg | 90 | 21 |
| New patient office or other outpatient visit, 45-59 minutes | 43 | 43 |
| Photography of the retina | 21 | 15 |
| 2d ultrasound scan of eye tissue and structures | 20 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Philadelphia, PA | 51 |
| Ketorolac Tromethamine Other prescribers in Philadelphia, PA | 48 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Philadelphia, PA | 47 |
| Brimonidine Tartrate Other prescribers in Philadelphia, PA | 21 |
| Difluprednate | 13 |
| Latanoprost Other prescribers in Philadelphia, PA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 28 payments worth $29,827 in total to this clinician.
| Astellas Pharma US Inc | $6,874 |
|---|---|
| Ocular Therapeutix, Inc. | $5,012 |
| Genentech USA, Inc. | $4,500 |
| AbbVie Inc. | $3,866 |
| Apellis Pharmaceuticals, Inc. | $3,684 |
| Astellas Pharma Global Development | $2,968 |
| F. Hoffmann-la Roche AG | $2,758 |
| Harrow Eye, LLC | $115 |
| Consulting Fee | $19,998 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $8,500 |
| Food and Beverage | $870 |
| Travel and Lodging | $459 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genentech USA, Inc. Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) Vabysmo · Immunology and Ophthalmology | $4,500 |
| Apellis Pharmaceuticals, Inc. Jun 6, 2025 | Consulting Fee Syfovre · Ophthalmology | $3,024 |
| Astellas Pharma US Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $3,000 |
| Astellas Pharma Global Development Apr 3, 2025 | Consulting Fee Izervay · Ophthalmology | $2,968 |
| F. Hoffmann-la Roche AG May 5, 2025 | Consulting Fee | $2,700 |
| Astellas Pharma US Inc Mar 21, 2025 | Consulting Fee Izervay · Ophthalmology | $2,084 |
| Ocular Therapeutix, Inc. May 9, 2025 | Consulting Fee | $2,000 |
| Ocular Therapeutix, Inc. Oct 29, 2025 | Consulting Fee | $2,000 |
| AbbVie Inc. Jun 18, 2025 | Consulting Fee | $1,025 |
| AbbVie Inc. Oct 16, 2025 | Consulting Fee | $1,025 |
All 16 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Ocular Therapeutix, Inc. Oct 29, 2025 | Consulting Fee | $2,000 |
| AbbVie Inc. Oct 27, 2025 | Consulting Fee | $1,025 |
| AbbVie Inc. Oct 16, 2025 | Consulting Fee | $1,025 |
| AbbVie Inc. Sep 4, 2025 | Consulting Fee | $769 |
| Ocular Therapeutix, Inc. Aug 26, 2025 | Consulting Fee | $1,000 |
| AbbVie Inc. Jun 18, 2025 | Consulting Fee | $1,025 |
| Apellis Pharmaceuticals, Inc. Jun 6, 2025 | Consulting Fee Syfovre · Ophthalmology | $3,024 |
| Genentech USA, Inc. Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) Vabysmo · Immunology and Ophthalmology | $4,500 |
| Astellas Pharma US Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $1,000 |
| Ocular Therapeutix, Inc. May 9, 2025 | Consulting Fee | $2,000 |
| F. Hoffmann-la Roche AG May 5, 2025 | Consulting Fee | $2,700 |
| Astellas Pharma US Inc Apr 16, 2025 | Travel and Lodging Izervay · Ophthalmology · travel to Pittsburgh, PA | $459 |
| Astellas Pharma US Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Izervay · Ophthalmology | $3,000 |
| Astellas Pharma Global Development Apr 3, 2025 | Consulting Fee Izervay · Ophthalmology | $2,968 |
| Astellas Pharma US Inc Mar 21, 2025 | Consulting Fee Izervay · Ophthalmology | $2,084 |
| Apellis Pharmaceuticals, Inc. Mar 7, 2025 | Consulting Fee Syfovre · Ophthalmology | $378 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.